Israel Englander’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Israel Englander’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-370,759	Closed	-$111K	–	6854
2023 Q2	$111K	Buy	370,759 +138,824	+60%	+$41.9K	﹤0.01%	5307
2023 Q1	$100K	Buy	231,935 +82,461	+55%	+$63.3K	﹤0.01%	5429
2022 Q4	$176K	Buy	149,474 +108,384	+264%	+$177K	﹤0.01%	5378
2022 Q3	$95K	Sell	41,090 -2,409	-6%	-$6.31K	﹤0.01%	5990
2022 Q2	$96K	Sell	43,499 -8,514	-16%	-$59K	﹤0.01%	5958
2022 Q1	$501K	Sell	52,013 -419,476	-89%	-$3.76M	﹤0.01%	5123
2021 Q4	$4.68M	Buy	471,489 +133,203	+39%	+$1.32M	﹤0.01%	2966
2021 Q3	$3.35M	Buy	338,286 +290,451	+607%	+$2.85M	﹤0.01%	3337
2021 Q2	$469K	Buy	+47,835	New	+$466K	﹤0.01%	5365

Israel Englander's GRNA Position: Q3 2023 in Review

Israel Englander sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 370,759 shares — an estimated $111K sold.

Israel Englander first reported a position in GRNA in Q2 2021 and held it in 9 quarters. The position peaked at $4.68M in Q4 2021. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

Israel Englander reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
Israel Englander sold 370,759 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023, an estimated $111K.
Israel Englander first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2021 and held it in 9 quarters.
Israel Englander's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $4.68M in Q4 2021.
0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.